A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
Titel:
A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors
Auteur:
Mettu, Niharika B. Niedzwiecki, Donna Rushing, Christel Nixon, Andrew B. Jia, Jingquan Haley, Sherri Honeycutt, Wanda Hurwitz, Herbert Bendell, Johanna C. Uronis, Hope